MedTrace Logo

EndoForce Post Approval Study

NCT07146854 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-01-21

No results posted yet for this study

Summary

The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.

Conditions

  • End Stage Renal Disease (ESRD)

Sponsors & Collaborators

  • Phraxis, Inc.

    lead INDUSTRY

Principal Investigators

  • Ari Kramer, MD · Spartanburg Regional Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-13
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07146854 on ClinicalTrials.gov